SPOTLIGHT -
FDA Approval Sought for Lumisight Optical Imaging Agent to Assist in Intraoperative Breast Cancer Detection
FDA Approval Insights: Sacituzumab Govitecan in HR-positive, HER2-negative Breast Cancer
Patritumab Deruxtecan Continues to Generate Responses in Previously Treated EGFR-Mutated NSCLC and HER3-Expressing Breast Cancer
Nair Notes the Benefits of Yoga as a Complementary Therapy in Nonmetastatic Breast Cancer
PARP7 Inhibitor RBN-2397 Has Tolerable Safety Profile in Solid Tumors
Media Training Helps Investigators, Institutions Shine
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
